Geode Capital Management
TVTX icon

Geode Capital Management’s Travere Therapeutics TVTX Stock Holding History

Geode Capital Management’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$70.4M Buy
2,369,559
+226,064
+11% +$6.76M ﹤0.01% 1304
2025
Q4 		$81.9M Buy
2,143,495
+5,465
+0.3% +$178K 0.01% 1211
2025
Q3 		$51.1M Buy
2,138,030
+134,329
+7% +$2.53M ﹤0.01% 1452
2025
Q2 		$29.7M Buy
2,003,701
+27,040
+1% +$448K ﹤0.01% 1743
2025
Q1 		$35.4M Buy
1,976,661
+134,360
+7% +$2.73M ﹤0.01% 1575
2024
Q4 		$32.1M Buy
1,842,301
+111,256
+6% +$1.97M ﹤0.01% 1692
2024
Q3 		$24.2M Buy
1,731,045
+64,744
+4% +$675K ﹤0.01% 1877
2024
Q2 		$13.7M Buy
1,666,301
+105,413
+7% +$710K ﹤0.01% 2133
2024
Q1 		$12M Buy
1,560,888
+39,158
+3% +$330K ﹤0.01% 2211
2023
Q4 		$13.7M Buy
1,521,730
+81,086
+6% +$590K ﹤0.01% 2149
2023
Q3 		$12.9M Buy
1,440,644
+48,888
+4% +$690K ﹤0.01% 2102
2023
Q2 		$21.4M Buy
1,391,756
+175,182
+14% +$3.19M ﹤0.01% 1807
2023
Q1 		$27.4M Buy
1,216,574
+119,563
+11% +$2.54M ﹤0.01% 1594
2022
Q4 		$23.1M Buy
1,097,011
+36,605
+3% +$776K ﹤0.01% 1672
2022
Q3 		$26.1M Buy
1,060,406
+35,481
+3% +$917K ﹤0.01% 1543
2022
Q2 		$24.8M Sell
1,024,925
-33,977
-3% -$854K ﹤0.01% 1611
2022
Q1 		$27.3M Buy
1,058,902
+15,619
+1% +$415K ﹤0.01% 1683
2021
Q4 		$32.4M Buy
1,043,283
+59,305
+6% +$1.67M ﹤0.01% 1631
2021
Q3 		$23.9M Sell
983,978
-21,461
-2% -$394K ﹤0.01% 1834
2021
Q2 		$14.7M Buy
1,005,439
+48,193
+5% +$951K ﹤0.01% 2193
2021
Q1 		$23.9M Buy
957,246
+199,385
+26% +$5.51M ﹤0.01% 1757
2020
Q4 		$20.7M Buy
757,861
+29,437
+4% +$687K ﹤0.01% 1697
2020
Q3 		$13.4M Buy
728,424
+60,764
+9% +$1.18M ﹤0.01% 1781
2020
Q2 		$13.6M Buy
667,660
+7,729
+1% +$123K ﹤0.01% 1749
2020
Q1 		$9.63M Buy
659,931
+53,074
+9% +$799K ﹤0.01% 1754
2019
Q4 		$8.62M Buy
606,857
+18,180
+3% +$232K ﹤0.01% 2115
2019
Q3 		$6.82M Sell
588,677
-39,561
-6% -$654K ﹤0.01% 2194
2019
Q2 		$12.6M Buy
628,238
+92,800
+17% +$1.83M ﹤0.01% 1774
2019
Q1 		$12.1M Buy
535,438
+52,355
+11% +$1.16M ﹤0.01% 1767
2018
Q4 		$10.9M Buy
483,083
+24,468
+5% +$609K ﹤0.01% 1728
2018
Q3 		$13.2M Buy
458,615
+14,873
+3% +$425K ﹤0.01% 1722
2018
Q2 		$12.1M Buy
443,742
+75,659
+21% +$2.01M ﹤0.01% 1730
2018
Q1 		$8.23M Buy
368,083
+24,110
+7% +$574K ﹤0.01% 1905
2017
Q4 		$7.25M Buy
343,973
+24,615
+8% +$563K ﹤0.01% 1975
2017
Q3 		$7.95M Buy
319,358
+5,521
+2% +$122K ﹤0.01% 1895
2017
Q2 		$6.08M Sell
313,837
-20,157
-6% -$366K ﹤0.01% 2020
2017
Q1 		$6.17M Sell
333,994
-10,220
-3% -$200K ﹤0.01% 1963
2016
Q4 		$6.51M Buy
344,214
+68,420
+25% +$1.4M ﹤0.01% 1877
2016
Q3 		$6.17M Buy
275,794
+4,989
+2% +$95K ﹤0.01% 1830
2016
Q2 		$4.82M Buy
270,805
+8,076
+3% +$131K ﹤0.01% 1939
2016
Q1 		$3.59K Buy
262,729
+23,275
+10% +$353K ﹤0.01% 2087
2015
Q4 		$4.62M Buy
239,454
+14,773
+7% +$295K ﹤0.01% 1929
2015
Q3 		$4.55M Buy
224,681
+3,373
+2% +$99.9K ﹤0.01% 1896
2015
Q2 		$7.34M Buy
221,308
+54,507
+33% +$1.49M ﹤0.01% 1634
2015
Q1 		$4M Buy
166,801
+37,769
+29% +$576K ﹤0.01% 1996
2014
Q4 		$1.58M Buy
129,032
+42,639
+49% +$441K ﹤0.01% 2571
2014
Q3 		$779K Buy
86,393
+53,298
+161% +$627K ﹤0.01% 2939
2014
Q2 		$388K Buy
33,095
+2,431
+8% +$32.9K ﹤0.01% 3272
2014
Q1 		$652K Buy
+30,664
New +$471K ﹤0.01% 3019

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Geode Capital Management's TVTX Position: Q1 2026 in Review

Geode Capital Management increased its Travere Therapeutics (TVTX) stake by 11% in Q1 2026, buying an estimated $6.76M and bringing the position to 2,369,559 shares worth $70.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1304.

Geode Capital Management first reported a position in TVTX in Q1 2014 and has held it in 49 quarters since. The position peaked at $81.9M in Q4 2025. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Geode Capital Management held 2,369,559 shares of Travere Therapeutics worth $70.4M as of Q1 2026.
  • Geode Capital Management bought 226,064 Travere Therapeutics shares in Q1 2026, an estimated $6.76M.
  • Travere Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #1304 holding.
  • Geode Capital Management first reported a position in Travere Therapeutics in Q1 2014 and has held it in 49 quarters since.
  • Geode Capital Management's Travere Therapeutics position peaked at $81.9M in Q4 2025.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.